Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/f72c163c-734b-4be4-bacc-7fc3aa9e96fb/

UNH

UnitedHealth Group Incorporated
Chart
€347.00
Latest Week 2026-06-05
Snapshot 2026-06-07 · 0.0w · Fresh
0.26
OS Score
28.0%
Value
26.0%
Quality
78.0%
Momentum
6/9
F-Score
0.270
QV
Strategy Eligibility
2 of 23 passing
OS Composite
Trending Value
Quality × Value
🏛
Cornerstone Value
🌿
Cornerstone Growth
💎
Deep Value
VC2 Cheapest
📐
EBITDA/EV
Veiled Value
Piotroski Bargains
🔬
Quality Compounders
📈
Consistent Earners
🌱
GARP
🔄
Shareholder Yield
3.1%
💰
High Yield
🚀
Momentum Leaders
12-1 24%
Market Leaders
Tiny Titans
🔍
Small Cap Value
🛡
Low Volatility
🏷
Sector Cheapest
🧠
Capital Allocators
Risk-Adj Momentum
V
Value Analysis
Cheapness relative to fundamentals
28.0%ile
P/E
26.2×
P/S
0.7×
P/B
3.2×
E/P
0.0382
FCF Yield
0.054
EBITDA/EV
0.063
SH Yield
0.031
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
71.00000000
/100 — 1=cheapest
VC2 (Trending Value)
68.00000000
/100
VC3 (Buyback)
68.00000000
/100
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
26.0%ile
ROE
0.123
ROA
0.039
Net Margin
0.027
Op Margin
0.042
GPA
0.270
Current
0.80
F-Score
6/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.118
Earn Growth
-0.155
Stability
0.733
lower=better
Accruals
-0.036
lower=better
5yr Consist
No
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
78.0%ile
6M Return
24.1%
12M Return
36.0%
12-1 Mom
24.4%
Risk-Adj
0.52
Vol 252d
46.8%
Vol 60d
87.2%
↑ Expanding
Max DD 12M
-27.4%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of 24% is very strong — a clear uptrend. Near-term vol (87%) is expanding vs long-term (47%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.26
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
Sector Context
Healthcare · 79 peers
Sector Value %ile
25.0%
Sector Quality %ile
17.5%
P/E z-score
0.16
P/B z-score
-0.17
Sector Avg OS
49.6%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
MED MEDICLIN Aktiengesellschaft 99.0% 97.0% 83.0% 79.0%
DRW8 Drägerwerk AG & Co. KGaA 96.0% 93.0% 62.0% 78.0%
DRW3 Drägerwerk AG & Co. KGaA 95.0% 85.0% 62.0% 80.0%
AJ91 DocCheck AG 95.0% 82.0% 88.0% 70.0%
CBHD Coloplast A/S 94.0% 98.0% 91.0% 22.0%
M12 M1 Kliniken AG 93.0% 70.0% 89.0% 76.0%
BRM Bristol-Myers Squibb Company 92.0% 61.0% 98.0% 74.0%
NOV Novo Nordisk A/S 91.0% 98.0% 78.0% 20.0%
Factor Interactions
Volatility Expanding
60-day vol (87%) significantly exceeds 252-day (47%). Near-term risk is elevated.
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
C
52.8% avg (7 factors)
Quality
D
35.2% avg (7 factors)
Momentum
B
61.2% avg (4 factors)
Risk
D
38.6% avg (1 factors)
Elevated risk profile — position sizing should reflect the higher volatility.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Factor Persistence1 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.260—1
Value %ile0.280—1
Quality %ile0.260—1
Momentum %ile0.780—1
F-Score6.000—0
Confidence0.939—1
Volatility0.468—1
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
26.15
Earnings Yield (E/P)
0.0382
Price / Sales
0.70
Price / Book
3.22
Price / Cash Flow
13.60
FCF Yield
5.4%
EBITDA / EV
6.3%
Sales Yield (1/P·S)
1.2325
Shareholder Yield
Div + net buyback / mktcap
3.1%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
12.3%
Return on Assets
3.9%
Net Margin
2.7%
Operating Margin
4.2%
Gross Profit / Assets
Novy-Marx GPA
27.0%
Current Ratio
0.80
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.036
External Financing
Net issuance — lower=better
0.010
MomentumPrice trend strength over different horizons
6M Return
24.1%
12M Return
36.0%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
24.4%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
0.52
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
11.8%
Earnings Growth (YoY)
-15.5%
Earnings Stability (CV)
Lower = more stable
0.733
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
6
Dividend Yield
2.5%
Buyback Yield
0.6%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
71
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
68
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
68
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity